Fig. 4
From: Circulating CD24/Siglec-10 biomarkers predict post-resuscitation outcomes in a cardiac arrest cohort
Receiver operating characteristic curves of variables for predicting 28-day poor neurological prognosis following ROSC. *P < 0.05; AUC, areas under the curves; GO-FAR 2, the Good Outcome Following Attempted Resuscitation (GO-FAR) 2 score; IHCA, in-hospital cardiac arrest; IL-6D1,D3,D7, interleukin-6 on day 1, 3 and 7 after ROSC; MIRACLE2, a risk score for early prediction of neurological outcome after out-of-hospital cardiac arrest; NAD1,D3,D7, the relative activity of neuraminidase on days 1, 3 and 7 after ROSC; NSED1,D3,D7, neuron specific enolase on days 1, 3 and 7 after ROSC; OHCA, out-of-hospital cardiac arrest; sCD24D1, D3,D7, soluble cluster of differentiation 24 on days 1, 3 and 7 after ROSC; SAD1,D3,D7, Sialic acid on days 1, 3 and 7 after ROSC; sSiglec-10D1,D3,D7, soluble Siglec-10 on days 1, 3 and 7 after ROSC.
